No significant differences were observed in sex, age, previous history of fungal infection, neutrophil count, CD4+ and CD8+ counts, disease classification, chemotherapy regimen, preventive antifungal agents, or disease outcome between the groups. The gene discussed is CD4; the disease is fungal infectious disease.